Clovis Oncology Inc (NASDAQ:CLVS) - Share price - Overview

Stock Report

Clovis Oncology Inc CLVS

Last Price
$61.19

Day Change
-1.80|-2.86%

As of 22/02/2017
16:00:00 EST | USD
Minimum 15 Minutes Delay.

Last Close62.99
Day Range61.04 - 63.67
Mkt Cap2.71Bil
52-Wk Range11.57 - 67.16
Yield %-
ISINUS1894641000
Volume1,930,400
P/E-5.88
P/S-
P/CF-8.17

Share Price

Financials
201320142015
More ...
Income Statement
Revenue0.0013.630.00
Operating Income-83.77-158.46-376.72
Net Income-84.53-160.03-352.86
Basic EPS-2.95-4.72-9.79
Avg. Diluted Shares Outstanding293436
Balance Sheet
Current Assets328.60491.17539.70
Non Current Assets321.04295.03173.69
Total Assets649.64786.21713.39
Current Liabilities20.9547.7775.58
Total Liabilities151.75454.58412.74
Total Equity497.89331.63300.65
Cash Flow
Operating Cash Flow-71.71-117.05-253.07
Capital Expenditure-0.12-2.29-3.04
Free Cash Flow-71.83-119.34-256.10

In millions, except "Basic EPS". Currency is USD.

Company Profile

Clovis Oncology Inc is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and additional international markets.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

309
Key Stats
More ...
Price/Earning TTM-6.05
Price/Book48.96
Price/Sales TTMInfinity
Rev Growth (3 year avg)0.00
EPS Growth (3 year avg)-
Operating Margin % TTM-Infinity
Net Margin % TTM-Infinity
ROE TTM-111.62
Debt/Equity0.93
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.